High efficiency antigen presentation by thyroglobulin-primed murine splenic B cells.

Area of Science:

• Immunology
• Cellular Biology
• Autoimmunity

Background:

• Thyroglobulin is a key antigen in autoimmune thyroid diseases.
• The role of B cells in presenting antigens to T cells is well-established, but antigen concentration effects are less understood.

Purpose of the Study:

• To investigate the role of B cells in presenting low-dose thyroglobulin antigen to T cells.
• To elucidate the mechanism by which B cells present thyroglobulin and its implications for maintaining immune responses.

Main Methods:

• In vivo B cell priming with mouse or rat thyroglobulin.
• Antigen presentation assay using CH9 T cell hybridoma.
• Interleukin-2 release measurement.
• Flow cytometry using monoclonal antibodies (anti-Thy-1.2, 33D1) and F(ab')2 fragments.

Main Results:

• Primed B cells presented thyroglobulin antigen at very low concentrations to specific T cells.
• Antigen presentation was dependent on B cells but not T cells or dendritic cells.
• Presentation was specific to the priming antigen and blocked by anti-F(ab')2 treatment.

Conclusions:

• Primed B cells are capable of presenting low-dose thyroglobulin antigens.
• This B cell-mediated antigen presentation may sustain autoreactive T cell responses in vivo, even with minimal antigen availability.